PUBLISHER: KBV Research | PRODUCT CODE: 1395856
PUBLISHER: KBV Research | PRODUCT CODE: 1395856
The Asia Pacific Ureteral Stents Market would witness market growth of 7.4% CAGR during the forecast period (2023-2030). In the year 2021, the Asia Pacific market's volume surged to 3,228.2 thousand units, showcasing a growth of 6.8% (2019-2022).
Various urological disorders, including congenital abnormalities and conditions affecting the structure of the urinary system, may require these stents. These devices aid in maintaining urinary function and preventing complications associated with abnormal anatomical structures. Ureteral strictures, characterized by the narrowing of the ureter, can impede urine flow. In some cases, these stents are utilized as a preventive measure, reducing the risk of stricture formation and maintaining the patency of the urinary tract.
Furthermore, the market has seen a notable trend toward using biocompatible materials in ureteral stent construction. Innovations in material science aim to reduce the risk of adverse reactions and improve patient comfort during stent placement. Biodegradable stents are also being explored to eliminate the need for additional removal procedures. Continual scientific and technological endeavors are devoted to the improvement of ureteral stent design in order to enhance its effectiveness and patient outcomes. Innovations include modifications to stent shape, size, and surface characteristics to minimize discomfort, prevent encrustation, and optimize urine flow.
The Government of India has recognized the importance of addressing the health needs of older people. Various policies and programs have been initiated to enhance healthcare services for older individuals. The Government has various healthcare programs encompassing various medical conditions, including urological disorders. The fundamental aim of the National Programme for Health Care of the Elderly is to furnish senior citizens with distinct, specialized, and all-encompassing healthcare services across different tiers of the State healthcare delivery system, encompassing outreach initiatives as well. Thus, the aging population in various nations in the Asia Pacific and increased initiatives for elderly health in countries like India will help expand the market.
The China market dominated the Asia Pacific Ureteral Stents Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $65.1 million by 2030. The Japan market is registering a CAGR of 6.6% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 8% during (2023 - 2030).
Based on End User, the market is segmented into Hospitals, and Ambulatory Surgical Centers (ASCS) & Clinics. Based on Material, the market is segmented into Metallic Stents and Polymer Stents (Silicone Stents, Hybrid Stents, and Polyurethane Stents). Based on Product, the market is segmented into Double Pigtail Stent, Open/Closed Pigtail Stent, and Multiloop Stents. Based on Application, the market is segmented into Kidney Stones, Kidney Transplantation, Urinary Incontinence, Tumors, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, B. Braun Melsungen AG, Coloplast Group, Medline Industries, Inc., Allium Ltd, Cook Medical, Inc. (Cook Group), Pnn Medical A/S, Teleflex, Inc., Olympus Corporation and Becton, Dickinson, and Company
Market Segments covered in the Report:
By End User (Volume, Thousand Units, Revenue, USD Million, 2019-30)
By Material (Volume, Thousand Units, Revenue, USD Million, 2019-30)
By Product (Volume, Thousand Units, Revenue, USD Million, 2019-30)
By Application (Volume, Thousand Units, Revenue, USD Million, 2019-30)
By Country (Volume, Thousand Units, Revenue, USD Million, 2019-30)
Companies Profiled
Unique Offerings from KBV Research